Introduction
Ethiopia is characterized by great physiogeographic variation that accentuated the diversity of plant and animal life (Abebe and Ayehu, 1993) . The Ethiopian fl ora comprises more than 7000 species of higher plants, of which about 12% are endemic (Gebre Egziabher, 1991) ; about 715 species of plants have been documented to be used as medicinal drugs (Abebe et al., 2003) . Medicinal plants are quite often employed in cultural and health care systems of many Ethiopians. Therefore, plants remain indispensable sources of preventive and curative traditional medicines for both human beings and livestock. Most of the time, medicinal plants comprise 87% of traditional medical preparations (Abebe and Ayehu, 1993; Abebe et al., 2003) . Indeed, many controlled clinical studies have shown the therapeutic values of plant extracts used in phytotherapy (Wink, 2008) . In modern medicine, however, a single compound is usually preferred for treatment of a particular disease. Nevertheless, there are times when a complex mixture of plant secondary metabolites is preferred to a single compound especially when therapeutic effect is additive or synergistic (Wink, 2008) .
The African trypanosomes are protozoan blood parasites and mainly transmitted by tsetse fl ies of the genus Glossina. The diseases caused by these pathogenic protozoans are fatal and are called sleeping sickness in humans and nagana in domestic livestock (Brun et al., 2010) . Human sleeping sickness is caused by two subspecies of Trypanosoma brucei namely: T. b. gambiense and T. b. rhodesiense (Brun et al., 2010 In Africa and elsewhere in the world, natural products of plant origin are culturally accepted as alternative medicine and/or complementary medicine to the modern drugs. However, the problem with this type of traditional medicine in Africa and particularly in Ethiopia is that the traditional healers (herbalists) do not tell the composition or even the dose of the putative therapeutic preparation. Moreover, they pass their knowledge secretively to the most trusted and knowledgeable person of their own families. It is highly likely that indigenous knowledge of folk medicine might be lost. To mitigate the aforementioned problem, over the last three decades various scholars have documented the traditional medicinal uses of Ethiopian plants. But, only a few comprehensive pharmacological or biological studies have been carried out to validate the putative medicinal uses of these traditional medicines. Sometimes, the application of traditional medicinal plants involves a magico-religious approach which is not totally related to the causative agent or specifi c symptoms of diseases like trypanosomiasis. There is also little or no information on the toxicity of medicinal plants being used in the traditional medical practices.
The present study was thus designed with the primary objective to identify and validate 30 medicinal plants of Ethiopia as potential candidates for the treatment of trypanosomiasis. In addition, the present study was carried out to document the cytotoxicity of these plants against human leukaemia (HL-60) cells as new anticancer substances are also in need. A comparison of IC 50 values of extracts on T. b. brucei with respect to their corresponding cytotoxicity to HL-60 cells can serve as a guide to the initial selection of extracts for early drug discovery or phytotherapy of trypanosomiasis.
Material and Methods

Reagents
Fetal bovine serum, MEM, and RPMI 1640 media were purchased from Invitrogen (Karlsruhe, Germany). Resazurin and diminazene aceturate were purchased from Sigma-Aldrich (Steinheim, Germany).
Plant materials
The plants were collected from different parts of Ethiopia at different times between December 20, 2007 and February 5, 2008 by one of us (E. N.) from their natural habitats. Plant samples were identifi ed by Mr. Melaku Wondafrash (Addis Ababa University, Ethiopia) and deposited at National Herbarium, Addis Ababa University, Ethiopia and at Department of Biology, Institute of Pharmacy and Molecular Biotechnology, Heidelberg, Germany for further reference.
Preparation of plant crude extracts
The parts of each plant investigated in this study were ground and macerated in MeOH and CH 2 Cl 2 , respectively, and left on a shaker for two consecutive days. Extracts were then fi ltered and evaporated to dryness under reduced pressure using a rotary evaporator (Büchi, Labortechnik, Essen, Germany) at 45 °C.
Cell cultures
The human myeloid cell line HL-60 was obtained from Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSMZ, Braunschweig, Germany). Trypanosoma brucei brucei TC221 bloodstream form was initially obtained from Prof. Peter Overath (Max-Planck Institut für Biologie, Tübingen, Germany) and was continuously maintained in our laboratory.
Bloodstream forms of T. b. brucei TC221 cells were grown in Baltz medium (Baltz et al., 1985) supplemented with 20% inactivated fetal bovine serum and 1% penicillin-streptomycin whereas HL-60 cells (human myeloid cell line) were grown in RPMI 1640 medium supplemented with 0.2 mM L-glutamine, 1% penicillin-streptomycin, and 10% heat-inactivated fetal bovine serum. Both cell types were incubated in a humifi ed atmosphere containing 5% CO 2 at 37 °C.
Trypanocidal and cytotoxicity assays
The extracts and compounds were dissolved in dimethyl sulfoxide (DMSO). The extracts were further serially diluted with the medium in a two-fold fashion into seven different concentrations so as to attain fi nal concentrations ranging from 250 to 3.91 μg/mL in 96-well plates. Each concentration of the drug was tested in triplicate, each test was repeated twice. The solvent DMSO did not exceed 1.25% in the medium that contained the highest concentration of extract tested. Wells containing DMSO as well as wells without DMSO were included in the experiment.
Both T. b. brucei and HL-60 cells were seeded into 96 wells at a density of 1 · 10 4 cells per 100 μL of medium. The cells were incubated with the plant extracts for a total of 48 h. The antitrypanosomal and cytotoxic activities of extracts were evaluated using resazurin as cell proliferation indicator dye with some modifi cations after Rolón et al. (2006) . Briefl y, 10 μL and 6 μL of resazurin, respectively, were added to trypanosome and HL-60 cell cultures, and the mixtures were incubated for 24 h and 6 h, respectively, before measuring the 96-well plates after 48 h of incubation. The absorbance of the plates was read using a Tecan plate reader (Männedorf, Switzerland) at dual wavelengths of 492 nm and 595 nm. The concentration of extracts or reference drug at which the growth of cells was inhibited by 50% was calculated from a dose-response curve by linear interpolation taking two contents, above and below 50% (Huber and Koella, 1993) .
Results
All the extracts tested against trypanosomes showed trypanocidal activities. It is remarkable that the extracts prepared from 19 plant species showed trypanocidal activity below an IC 50 value of 50 μg/mL (Table I) Table I .
Discussion
In Ethiopia a number of plants are used for the treatment of protozoan infections and several other diseases. The present study explored diverse plants belonging to different families with the aim of fi nding plant extracts that might be candidates for the treatment of trypanosomiasis. Some of the plants (Calpurnia aurea, Clausena anisata, Leonotis ocymifolia, and Withania somnifera) are used traditionally for the treatment of diseases caused by trypanosomes and leishmania (Kinetoplastidae). The CH 2 Cl 2 extracts prepared from three out of the four plants showed trypanocidal activity below an IC 50 value of 50 μg/mL. The most potent and promising plants as sources of trypanocidal agents (in decreasing order of trypanocidal activity) are Dovyalis abyssinica, Albizia schimperiana, Ocimum urticifolium, Acokanthera schimperi, and Chenopodium ambrosioides.
The CH 2 Cl 2 extract of Dovyalis abyssinica leaves was the most active trypanocidal agent with a high selectivity index (SI = 125.0). D. abyssinica contains dovyalicin-type spermidine alkaloids (Rasmussen et al., 2006) , which in part resemble the chemical structures of standard drugs (e.g. pentamidine), and therefore these compounds may be in part responsible for the biological activity of the plant. The second promising plant, Albizia schimperiana, contains spermine alkaloids as one of its active principles (Rukunga and Waterman, 1996) . Ocimum urticifolium contains eugenol as one of main active compounds in its essential oil (Chogo and Crank, 1981) . Acokanthera schimperi contains the cardiac glycoside ouabain as one of its active principles (Wink and van Wyk, 2008) . Chenopodium ambrosioides is also a promising plant as a possible source of trypanocidal agents. The trypanocidal effect of C. ambrosioides may be due to the major and anthelminthic compound ascaridole (Kiuchi et al., 2002) .
Looking at the cytotoxicity of extracts against human leukaemia cells (HL-60), MeOH and CH 2 Cl 2 extracts from Acokanthera schimperi, In conclusion, it might be rewarding to study the most active plants (Dovyalis abyssinica, Albizia schimperiana, Ocimum urticifolium, Acokanthera schimperi, and Chenopodium ambrosioides) in more detail for their exploitation in in vivo treatment of trypanosomiasis. The active constituents of the plants should also be isolated and optimized if they could either serve as drugs or lead structures for the development of new and more effective trypanocidal drugs. In our laboratory, isolation of total alkaloid extracts from the most active plants such as Dovyalis abyssinica is being pursued for the treatment of trypanosomiasis. 
